Condition

Acute Myeloid Leukemia With Gene Mutations clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Oral Decitabine plus Ivosidenib as first-line treatment for older or unfit adults with AML

  This study tests whether combining oral decitabine with ivosidenib can help older or unfit adults with AML that has an IDH1 mutation to reach remission.

  Recruiting at 6 sites Phase 2 PETHEMA Foundation · Aveiro and 19 other locations · NCT07507760

• Combining CPX-351 and ivosidenib for treating IDH1 mutated acute myeloid leukemia and high-risk myelodysplastic syndrome

  This study is testing a combination of two treatments, CPX-351 and ivosidenib, to see if they can help people with acute myeloid leukemia or high-risk myelodysplastic syndrome who have an IDH1 mutation.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT04493164

Related topics

Quick answers

How many Acute Myeloid Leukemia With Gene Mutations clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (1 trial), Portugal (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →